All articles — 3771 total
Owens Corning enters the week after earnings on a strong note. The stock jumped 5.1% on May 5 to close at $122.90. Yet beneath the relief rally, short sellers have been quietly rebuilding positions — and options…
Compass Diversified heads into its Q1 results — reported after the close on May 6 — carrying one of the stranger setups of the week: a CFO who bought the stock at $8.50 in early April and is sitting on a 37% gain, a…
Vanda Pharmaceuticals enters the post-Q1 stretch having just delivered a messy earnings print — but with a guidance raise that gives the bulls something to work with. The company reported Q1 EPS of -$0.82, missing the…
Brookdale Senior Living just reported Q1 2026 results, and the print gives the market something to chew on: EPS of -$0.03 came in line with expectations, but revenue of $764.9 million missed the consensus estimate of…
CF Industries reports Q1 2026 results on May 7, with the stock at $128.04 — right on top of analyst consensus — and a fleet of target increases that hasn't yet convinced the Street to upgrade its ratings. The analyst…
Galapagos NV dropped its Q1 2026 results after market close on May 6, delivering a split verdict that keeps the debate around this Belgian biotech very much alive. The headline read was mixed. Q1 EPS came in at $0.25,…
Alto Ingredients heads into its May 7 earnings report on a remarkable run — up 28% in a month and 13% on the week — yet the company's entire executive team sold shares just five weeks ago. The insider activity is the…
Herbalife enters a fresh week with a notable contradiction: the stock is up 17% over the past month, yet a cluster of insiders just rang the register at the top. The insider story is the sharpest angle this week. On…
Ormat Technologies walks into its Q1 2026 results — scheduled for May 7 — with a quietly charged setup. Short interest has risen steadily all month, options traders have turned more cautious than usual, and the stock…
Innoviva reported Q1 2026 results after the close on May 6, posting a massive EPS beat — $2.22 actual against a $0.36 consensus estimate — while revenue of $97.99 million came in slightly short of the $101.56 million…
ACADIA Pharmaceuticals enters the week of its earnings release with short interest at a four-month high — up 25% in just one month — yet the borrow market remains so loose it barely registers as friction. The…
MidCap Financial Investment Corporation heads into its Q1 earnings call on May 7 with shorts covering, borrow costs deflating, and options traders making a sharp pivot toward bullish positioning — an unusually aligned…
Universal Technical Institute filed its fiscal Q2 results after the close on May 6, beating EPS estimates by a penny while revenue of $221.4M came in fractionally short of the $221.6M consensus. The company reaffirmed…
Compass Minerals International heads into its fiscal Q2 earnings release — confirmed for May 7 — with its stock already pricing in good news, a 16% rally in a single month, and options traders positioned firmly on the…
KRO has put in a striking 22% gain over the past month — but the move has done almost nothing to dent short conviction, and earnings are one week away. The price recovery has been broad-based across commodity chemicals…
SOXX, the iShares Semiconductor ETF, enters the week having delivered its sharpest weekly gain in months — and the data behind it tells a story of forced covering, easing bearish conviction, and stubborn hedging that…
Dorchester Minerals, L.P. enters its Q1 2026 earnings report on May 7 with options positioning at its most defensive in months, even as the stock slips toward a fresh one-month low. Options traders have turned notably…
Safety Insurance Group heads into post-earnings trading with a notable earnings miss just landed — adjusted EPS came in at -$0.72 for Q1 2026, a sharp reversal from the $1.28 earned in the same quarter a year ago, even…
QIAGEN entered its Q1 2026 earnings week already nursing a 17% one-month decline. The report did nothing to arrest the slide — and the Street's response was swift and unanimous. Q1 sales came in at $492m, missing the…
RenaissanceRe Holdings heads into the back half of earnings season carrying a fresh post-results bruise and a wall of analyst target-price rewrites clustering tightly around the current share price. Q1 results landed…
